Liver Disease Diagnostics Market Report 2025 (Global Edition)

Global Liver Disease Diagnostics Market Report 2025 Market Size Split by Disease Type (Hepatitis, Cirrhosis, Liver Cancer, Non-Alcoholic Fatty Liver Disease (NAFLD)), by Diagnosis Technique (Imaging, ...

Liver Disease Diagnostics Market Report Description

We have various report editions of Liver Disease Diagnostics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Liver Disease Diagnostics Market Insights Video

Competitive Landscape of the Liver Disease Diagnostics Market

The competitive context of the liver disease diagnostics industry offers information broken down by competition. In-depth information is provided about the business's background, finances, earnings, prospective markets, R&D spending, emerging market efforts, international manufacturing locations and infrastructure, manufacturing capabilities, company advantages and disadvantages, introduction of products, goods length and dimension, and sector superiority. The earlier statistics only pertain to the companies' concentration on the liver disease diagnostics industry.

April 2024: Roche declared that the Phase III STARGLO trial achieved its main objective, which was long-term survival. A longer life span was observed in patients with returned or resistant (R/R) lymphoma of the large B cells (DLBCL) that had already undergone one round of treatment and were not eligible for an autologous stem cell transplant when given the combination of Columvi (glofitamab) using the drugs gemcitabine and treatment with (GemOx) instead of MabThera/Rituxan (rituximab) with GemOx. (Source: https://www.roche.com/media/releases/med-cor-2024-04-15) July 2024: Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), declared the release of a review article titled "Designed Recoverable Prevention of SpyCatcher Interaction Allows Quick Development of Bispecific Antibodies" in Environment Communications. This study shows how Bio-Rad's SpyLock technique can be used to quickly generate and evaluate bispecific antigens, which considerably speeds up the functionality confirmation procedure and helps identify those with the greatest potential. (Source: https://www.bio-rad.com/en-in/life-science-research/news/bio-rads-study-demonstrating-utility-its-spylock-technology-for-fast-generation-screening-bispecific-antibodies-published-nature-communications?ID=Bio-Rad-Publishes-in_1721753523) June 2024: Prisma Health and Siemens Healthineers established a ten-year collaboration to improve South Carolina's healthcare. The goals of this strategic collaboration are to improve medical care for Prisma Wellness's beneficiaries and the communities it serves, as well as to innovate treatment while training the staff. Siemens Healthineers and Prisma Health will work together to enhance the execution of health services, establish an Artificial Analytics Center with the aim of improving medical services, and install the newest healthcare equipment at all Prisma Health locations through this partnership. (Source: https://www.siemens-healthineers.com/press/releases/prisma)

Top Companies Market Share in Liver Disease Diagnostics Industry: (In no particular order of Rank)

• Abbott Laboratories
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Cosara Diagnostics Pvt Ltd.
• F. Hoffmann-La Roche Ltd.
• HORIBA Medical
• Laboratory Corporation of America Holdings
• Meril Life Sciences Pvt. Ltd.
• Qiagen N.V.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Liver Disease Diagnostics Market

Which Region Dominates the Liver Disease Diagnostics Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue because of the rising cost of medical services and the increasing number of patients with liver illnesses like alcoholism. Effective research and development investments in the medical management of liver disease, affordable reimbursements for medication, fast adoption of innovative treatments and technologies, an established medical facility, and an increasing importance on early detection and treatment.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the liver disease diagnostics market due to the region's significant populace as well as elevated rates of infectious hepatitis, non-alcoholic fatty, and liver tumors. Large populations, growing urbanization, higher levels of education and awareness of respiratory disorders, and better healthcare infrastructure are all also driving forces behind this expansion.

The current report Scope analyzes Liver Disease Diagnostics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Liver Disease Diagnostics Market

According to Cognitive Market Research, the global liver disease diagnostics market size was estimated at USD 41548.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 16619.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the liver disease diagnostics market with a market size of USD 13112.61 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. The nation's increasing investment in infrastructure.
• The Canada liver disease diagnostics market had a market share of USD 1994.31 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Canada's rise is due to the nation's rapid expansion in the healthcare industry.
• The Mexico liver disease diagnostics market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 1512.35 million in 2024.

Europe Liver Disease Diagnostics Market

According to Cognitive Market Research, the global liver disease diagnostics market size was estimated at USD 41548.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 12464.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• The United Kingdom liver disease diagnostics market had a market share of USD 2094.03 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. In the UK, liver disease diagnostics sales witness an upswing due to the nation's rising demand for innovative technology.
• The France liver disease diagnostics market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1146.73 million in 2024.
• According to Cognitive Market Research, the German liver disease diagnostics market size was valued at USD 2467.96 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. In Germany, Liver disease diagnostics surged due to the presence of major market players.
• The Italy liver disease diagnostics market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 1071.94 million in 2024.
• The Russia liver disease diagnostics market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 1931.99 million in 2024.
• The Spain liver disease diagnostics market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD 1022.09 million in 2024
• The Luxembourg liver disease diagnostics market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 386.40 million in 2024.
• The Portugal liver disease diagnostics market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 261.75 million in 2024.
• The Greece liver disease diagnostics market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 149.57 million in 2024.
• Rest of Europe's liver disease diagnostics market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 1931.99 million in 2024.

Asia Pacific Liver Disease Diagnostics Market

According to Cognitive Market Research, the global liver disease diagnostics market size was estimated at USD 41548.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 9556.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China liver disease diagnostics market size was valued at USD 4300.24 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Liver disease diagnostics surged in China due to the adoption of various technologies.
• The Japan liver disease diagnostics market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 1318.74 million in 2024.
• The India liver disease diagnostics market had a market share of USD 1146.73 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. India's supportive initiatives taken by the government.
• The South Korean liver disease diagnostics market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 955.61 million in 2024.
• The Australian liver disease diagnostics market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 496.92 million in 2024.
• The South East Asia liver disease diagnostics market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 659.37 million in 2024.
• The Rest of Asia Pacific liver disease diagnostics market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 678.48 million in 2024.

South America Liver Disease Diagnostics Market

According to Cognitive Market Research, the global Liver Disease Diagnostics Market size was estimated at USD 41548.2 Million, out of which the Latin America market has more than 5% share of the global revenue with a market size of USD 2077.41 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil liver disease diagnostics market size was valued at USD 889.13 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Liver disease diagnostics flourished in Brazil due to the innovation in customer habitats.
• Argentina's liver disease diagnostics market had a market share of USD 349.00 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. Argentina's technological advancements augment the demand.
• Colombia liver disease diagnostics market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 184.89 million in 2024.
• Peru liver disease diagnostics market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 170.35 million in 2024.
• Chile liver disease diagnostics market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 149.57 million in 2024.
• The Rest of Latin America's liver disease diagnostics market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 334.46 million in 2024.

Middle East Liver Disease Diagnostics Market

According to Cognitive Market Research, the global liver disease diagnostics market size was estimated at USD 41548.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 830.96 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031..

• The GCC Countries liver disease diagnostics market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 355.65 million in 2024 liver disease diagnostics sales flourish due to the presence of major market players.
• The Egypt liver disease diagnostics market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 87.25 million in 2024.
• The South Africa liver disease diagnostics market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 131.29 million in 2024. liver disease diagnostics sales flourish in South Africa due to technological advancements, and regulatory support.
• The Turkey liver disease diagnostics market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 71.46 million in 2024.
• The Nigeria liver disease diagnostics market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 87.25 million in 2024.
• The Rest of MEA liver disease diagnostics market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 98.05 million in 2024.

Liver Disease Diagnostics Market Analysis

Liver Disease Diagnostics Market Disease Type Segment Analysis

According to Cognitive Market Research, liver cancer stands out as the dominant category over the projected period because of the rising incidence of malignancy of the liver. The Industry is expected to grow at a faster rate due to a greater prevalence of illnesses such as drinking heavily, infection with a virus, and fatty liver caused by alcohol illnesses. Improvements in the early identification and diagnosis of liver cancer and an increase in the variety of treatments available, such as radiation treatment, particular treatments, immunotherapy treatment, and surgical procedures.

Hepatitis emerges as the fastest-growing category in the liver disease diagnostics market. Because of screening initiatives, a greater understanding and a growing number of viral liver infection diseases (hepatitis B and C), respectively, are responsible. Additional factors supporting segmental expansion include the increasing number of developments in antiviral medications and a stronger focus on prompt detection and therapy.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Liver Disease Diagnostics Industry. Request a Free Sample PDF!

Liver Disease Diagnostics Market Diagnostics TechniqueSegment Analysis

According to Cognitive Market Research, the dominant category is imaging because of an increasing number of actions made by significant participants in the liver condition diagnostics market to enhance cutting-edge imaging methods. The use of imaging techniques, including nuclear medicine, ultrasound, and computerized tomography scans, can be used to diagnose diseases like liver disease, malignancies, and liver fatty deposits by producing comprehensive images of the liver. When an optical inspection of the liver's composition and the identification of masses are required, imaging is the initial inexpensive diagnostic method that is frequently employed.

The fastest-growing category in the liver disease diagnostics market is biopsies because biopsies are useful for both assessing the extent of injury to the liver and detecting some liver illnesses that cannot be identified by scanning or blood examinations. When it comes to diagnosing inexplicable liver anomalies or assessing the degree of liver damage in chronic illnesses like hepatitis C, biopsies are frequently advised.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Liver Disease Diagnostics End-use Segment Analysis

Liver Disease Diagnostics Market End-Use Segment Analysis

According to Cognitive Market Research, the dominant category is laboratories. Laboratories that are independent or connected to clinics are experts in analyzing tissue and blood donations to find disorders in the liver. Laboratories might provide easier facilities and rapid diagnostic test procedures, which could lead to quicker findings for patients and healthcare professionals. The main purpose of labs is to provide regular laboratory examinations and screenings needed for liver disease diagnosis and surveillance.

The fastest-growing category in the liver disease diagnostics market is hospitals because hospitals offer rapid detection and treatment as well as offer patients the best care possible, which supports the expansion of the liver disorder diagnostics market. Furthermore, it is anticipated that the continuous advancement of the medical facilities would improve the current hospital amenities.

• Hospitals
• Laboratories
• Others

Author's Detail

Swasti Dharmadhikari

Research associate at Cognitive Market Research

LinkedIn

Profile

Swasti Dharmadhikari, an agile and achievement-focused market researcher with an innate ardor for deciphering the intricacies of the Service & Software sector. Backed by a profound insight into technology trends and consumer dynamics, she has committed herself to meticulously navigating the ever-evolving terrain of digital Services and software solutions.

Author's Conclusion